# EDGAR Filing Document

**Accession Number:** 0001411690
**File Stem:** 0001140361-25-034704
**Filing Date:** 2025-9
**Character Count:** 2565
**Document Hash:** 0e84f40643bc1bfdd43a28fa3a988ee9
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001140361-25-034704.hdr.sgml**: 20251120

**ACCESSION NUMBER**: 0001140361-25-034704

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20250911

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Bionano Genomics, Inc.
- **CENTRAL INDEX KEY:** 0001411690
- **STANDARD INDUSTRIAL CLASSIFICATION:** LABORATORY ANALYTICAL INSTRUMENTS [3826]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 261756290
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 9540 TOWNE CENTRE DRIVE
- **STREET 2:** SUITE 100
- **CITY:** SAN DIEGO
- **STATE:** CA
- **ZIP:** 92121
- **BUSINESS PHONE:** (858) 888-7600

**MAIL ADDRESS:**
- **STREET 1:** 9540 TOWNE CENTRE DRIVE
- **STREET 2:** SUITE 100
- **CITY:** SAN DIEGO
- **STATE:** CA
- **ZIP:** 92121

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Bionano Genomics, Inc
- **DATE OF NAME CHANGE:** 20190308

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** BioNano Genomics, Inc
- **DATE OF NAME CHANGE:** 20120703

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** BioNanomatrix Inc
- **DATE OF NAME CHANGE:** 20070906

September 11, 2025

#### VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

Washington, DC 20549

---

| | |
|:---|:---|
| **Re:** | **Bionano Genomics, Inc.<br> Registration Statement on Form S-1 (File No. 333-290187) – Concurrence in Acceleration Request** |

---

Ladies and Gentlemen:

H.C. Wainwright & Co., LLC ("<u>Wainwright</u>"), solely acting as placement agent on a best efforts basis in an offering pursuant to the registration statement on Form S-1 (File No. 333-290187) (the "<u>Registration Statement</u>"), hereby concurs in the request by Bionano Genomics, Inc. that the effective date of the above-referenced registration statement be accelerated to 9:00 A.M (Eastern Time), or as soon as practicable thereafter, on September 15, 2025, pursuant to Rule 461 under the Securities Act of 1933, as amended (the "<u>Securities Act</u>"). Wainwright affirms that it is aware of its obligations under the Securities Act as they pertain to the best efforts offering pursuant to the Registration Statement.

---

| | |
|:---|:---|
| Very truly yours, | Very truly yours, |
| **H.C. WAINWRIGHT & CO., LLC** | **H.C. WAINWRIGHT & CO., LLC** |
| By: | */s/ Edward. D. Silvera* |
|  | Name: Edward D. Silvera |
|  | Title: Chief Operating Officer |

---

------